Amenorrhea

Key takeaways

• Amenorrhea is the absence of menstrual periods for a prolonged time and always needs evaluation if pregnancy is ruled out.​
• It is broadly classified as primary amenorrhea (menses never started) and secondary amenorrhea (periods stopped for several months).​
• Causes range from normal physiology (pregnancy, breastfeeding) to hormonal disorders, low body weight, polycystic ovary syndrome, chronic disease, and structural problems of the reproductive tract.​
• Treatment focuses on correcting the underlying cause, protecting bone and cardiovascular health, and addressing fertility goals.​
• Persistent amenorrhea should prompt medical review and, when needed, early gynecology or endocrinology referral.​

Overview

Amenorrhea means not having menstrual periods when they would normally be expected, and it is a sign rather than a disease in itself. The condition can be temporary or long term, and ranges from being a normal life stage (for example, pregnancy) to indicating a significant hormonal, structural, or systemic problem. Early assessment of amenorrhea helps protect fertility, bone health, and overall wellbeing.​

What is amenorrhea?

Amenorrhea is defined as the absence of menstruation in someone of reproductive age who would usually be having periods. Clinically, amenorrhea is considered present when a person has never had a period by age 15 (primary amenorrhea) or when established periods stop for at least 3 months (if cycles were regular) or 6 months (if cycles were irregular) (secondary amenorrhea).​

In many cases, amenorrhea is due to normal situations such as pregnancy, breastfeeding, or menopause, but outside these contexts it generally indicates disruption along the hypothalamic–pituitary–ovarian–uterine axis. Because this axis interacts closely with nutrition, stress, chronic illness, and endocrine function, amenorrhea often acts as an early warning sign of broader health problems.​

Symptoms

The main symptom is the absence of menstrual bleeding for the time frames described. However, associated symptoms can provide important clues to the cause, for example:​

• Pelvic or abdominal pain, especially cyclic pain in primary amenorrhea with outflow tract obstruction.​
• Hot flushes, night sweats, vaginal dryness, and low libido suggesting low estrogen (e.g., ovarian insufficiency, hypothalamic amenorrhea).​
• Acne, excess facial/body hair, weight gain, and scalp hair thinning pointing to hyperandrogenism (e.g., polycystic ovary syndrome).​
• Headaches, visual changes, galactorrhea (milk discharge) suggesting pituitary tumors or prolactin disorders.​
• Symptoms of thyroid disease such as fatigue, cold intolerance, palpitations, or weight changes.​
• Eating disorder behaviors, intense exercise, high stress, or marked weight loss indicating functional hypothalamic amenorrhea.​

Psychological effects such as anxiety, low mood, and distress about fertility or body image are also common and merit active support.​

Causes and risk factors

Amenorrhea arises when any link in the hormonal or anatomical pathway that controls menstruation is disrupted. Causes are usually grouped as:​

• Physiological:
  • Pregnancy and breastfeeding (lactational amenorrhea).​
  • Perimenopause and menopause.​
• Hypothalamic causes:
  • Functional hypothalamic amenorrhea from low energy availability (under‑nutrition, eating disorders, excessive exercise), stress, or chronic illness.​
  • Systemic illness, severe weight loss, or acute medical stressors.​
• Pituitary causes:
  • Hyperprolactinemia (prolactin‑secreting adenomas, medications such as antipsychotics).​
  • Pituitary tumors, Sheehan’s syndrome, radiation or surgery affecting the gland.​
• Ovarian causes:
  • Primary ovarian insufficiency (premature ovarian failure) from genetic causes (e.g., Turner syndrome), autoimmune disease, chemotherapy, or radiation.​
  • Polycystic ovary syndrome (PCOS) with chronic anovulation and hyperandrogenism.​
  • Ovarian tumors or surgical removal.​
• Uterine and outflow tract causes:
  • Congenital anomalies such as Müllerian agenesis (absent uterus, vaginal abnormalities).​
  • Intrauterine adhesions (Asherman syndrome) after curettage, infection, or uterine surgery.​
  • Imperforate hymen, transverse vaginal septum, or cervical stenosis.​
• Endocrine and systemic causes:
  • Thyroid disease (hypo‑ or hyperthyroidism).​
  • Cushing syndrome, uncontrolled diabetes, chronic kidney or liver disease, celiac disease, inflammatory bowel disease.​
• Medication‑related and others:
  • Hormonal contraceptives, especially long‑acting progestogens, can cause temporary amenorrhea.​
  • Some psychiatric medications, opioids, and other drugs affecting prolactin or gonadotropin secretion.​

Risk factors include very low or very high BMI, high‑intensity athletics, eating disorders, family history of early menopause, chronic illnesses, and use of specific medications (e.g., antipsychotics, chemotherapy).​

Diagnosis

Assessment of amenorrhea aims to confirm the definition, identify or exclude pregnancy, and localize where along the reproductive axis the problem lies. A structured approach typically includes:​

• Detailed history:
  • Age at menarche, menstrual pattern, last menstrual period.​
  • Weight changes, diet, exercise, stress, and chronic illness.​
  • Galactorrhea, hot flushes, hirsutism, acne, headaches, visual symptoms.​
  • Sexual activity, contraception use, medication and substance history, family history of endocrine or reproductive disorders.​
• Physical examination:
  • Height, weight, BMI, and growth parameters in adolescents.​
  • Signs of puberty, androgen excess, thyroid disease, chronic illness, and acanthosis nigricans.​
  • Breast, pelvic, and speculum examination to assess genital anatomy and look for outflow tract anomalies.​
• Core investigations:
  • Urine or serum pregnancy test (always first).​
  • Serum FSH, LH, estradiol, prolactin, and thyroid‑stimulating hormone (TSH).​
  • Androgen profile (testosterone, DHEAS) if signs of hyperandrogenism.​
  • Pelvic ultrasound to evaluate uterus, ovaries, and endometrial thickness.​
• Targeted tests as indicated:
  • Karyotype for suspected chromosomal abnormalities (e.g., Turner syndrome).​
  • MRI of pituitary for suspected prolactinoma or other sellar mass.​
  • Hysteroscopy or sonohysterography for suspected intrauterine adhesions.​
  • Bone mineral density assessment when long‑term hypoestrogenism is suspected.​

Differential diagnoses

The differential diagnosis for amenorrhea is broad and overlaps with other menstrual and endocrine disorders. Important differentials to consider or rule out include:​

• Normal pregnancy, early pregnancy loss, and ectopic pregnancy.​
• Oligomenorrhea and irregular menses due to PCOS, thyroid disease, or hyperprolactinemia (where bleeding is reduced but not absent).​
• Primary dysmenorrhea or structural causes of pain where amenorrhea is not present.​
• Transgender and gender‑affirming hormone regimens suppressing menses.​
• Menopause and perimenopause in the appropriate age group.​

A diagnosis of functional hypothalamic amenorrhea, for example, is made only after other causes such as pregnancy, pituitary tumors, and primary ovarian insufficiency have been excluded.​

Types of amenorrhea

Amenorrhea is usually classified by timing and cause rather than by “stages” of disease.​

• By timing:
  • Primary amenorrhea:
    • No menses by age 15 in the presence of normal secondary sexual characteristics, or by 13 if there is no breast development.​
    • Often related to chromosomal abnormalities, gonadal dysgenesis, hypothalamic–pituitary disorders, or structural anomalies of the reproductive tract.​
  • Secondary amenorrhea:
    • Cessation of previously present menses for ≥3 months if cycles were regular, or ≥6 months if cycles were irregular.​
    • Causes include pregnancy, functional hypothalamic amenorrhea, PCOS, hyperprolactinemia, primary ovarian insufficiency, thyroid disease, chronic illness, uterine adhesions, and medication effects.​
• By underlying mechanism:
  • Hypothalamic (e.g., low weight, stress, exercise).​
  • Pituitary (e.g., prolactinoma, pituitary damage).​
  • Ovarian (e.g., PCOS, primary ovarian insufficiency).​
  • Uterine/outflow tract (e.g., Asherman syndrome, Müllerian agenesis).​
  • Other endocrine/systemic (e.g., thyroid disease, Cushing syndrome).​

This functional classification helps guide targeted investigations and treatment decisions.​

Treatment options

Management of amenorrhea is tailored to the cause, symptom burden, and the patient’s goals regarding fertility and menstrual regulation. General principles include:​

• Treating physiological causes:
  • Pregnancy, postpartum period, and menopause do not require treatment of amenorrhea itself, but associated symptoms or risks (e.g., menopausal bone loss) may need management.​
• Lifestyle and nutritional interventions:
  • For functional hypothalamic amenorrhea, restoring energy balance (increasing caloric intake, moderating exercise, and addressing stress) is central to resuming periods.​
  • Multidisciplinary support involving dietitians, mental health professionals, and sports medicine specialists is often beneficial.​
• Hormonal therapies:
  • Combined hormonal contraceptives, cyclic progestogens, or hormone replacement therapy to regulate cycles, provide endometrial protection, and improve hypoestrogenic symptoms if not contraindicated.​
  • Estrogen–progestin replacement in primary ovarian insufficiency to protect bone and cardiovascular health until the usual age of menopause.​
  • Dopamine agonists (e.g., cabergoline, bromocriptine) to treat hyperprolactinemia and restore ovulatory cycles.​
• Ovulation induction and fertility treatment:
  • Letrozole or clomiphene citrate, sometimes with gonadotropins or assisted reproductive technologies, for patients desiring pregnancy with anovulatory conditions such as PCOS or hypothalamic amenorrhea after lifestyle measures.​
• Surgical and procedural treatments:
  • Hysteroscopic adhesiolysis for intrauterine adhesions (Asherman syndrome).​
  • Surgical correction of obstructive anomalies such as imperforate hymen or transverse vaginal septum.​
  • Surgery or radiotherapy for pituitary or ovarian tumors, usually coordinated with endocrinology and neurosurgery.​
• Management of coexisting conditions:
  • Thyroid hormone replacement or antithyroid therapy for thyroid disease.​
  • Metabolic risk factor control (weight, lipids, blood pressure, glucose) and often metformin in PCOS.​

Psychological support, contraception counseling, and patient education about the meaning of amenorrhea and long‑term health implications are key aspects of comprehensive care.​

Possible complications

Untreated amenorrhea, particularly when linked to chronic hormonal imbalance or systemic disease, can lead to a range of complications.​

• Reproductive and gynecological:
  • Subfertility or infertility due to chronic anovulation or structural abnormalities.​
  • Increased risk of early pregnancy loss when underlying conditions such as poorly controlled endocrine disease persist.​
  • Endometrial hyperplasia and cancer risk in chronic anovulation with unopposed estrogen (e.g., PCOS).​
• Bone and metabolic:
  • Low bone mineral density, osteopenia, and osteoporosis in long‑term hypoestrogenic states (hypothalamic amenorrhea, primary ovarian insufficiency, untreated hyperprolactinemia).​
  • Increased fracture risk, particularly of vertebrae and hips, if bone health is not proactively managed.​
• Cardiovascular and systemic:
  • Adverse lipid profiles and cardiovascular risk in premature hypoestrogenism and metabolic syndrome associated with PCOS.​
  • Complications of the underlying systemic diseases such as celiac disease, inflammatory bowel disease, or pituitary tumors.​
• Psychosocial:
  • Body image concerns, anxiety, depression, and relationship stress related to infertility or perceived loss of femininity.​

Early identification and treatment of amenorrhea significantly reduce the risk of these long‑term complications.​

Prevention

Not all causes of amenorrhea are preventable, particularly genetic and congenital conditions, but many risk factors can be modified.​

• Maintain a balanced approach to nutrition and exercise:
  • Avoid extreme dieting, rapid weight loss, or very low body fat levels, particularly in adolescents and athletes.​
  • Ensure adequate calcium, vitamin D, and general nutrient intake for bone and hormonal health.​
• Monitor stress and mental health:
  • Address chronic psychological stress, anxiety, and disordered eating early with appropriate professional support.​
• Manage chronic conditions and medications:
  • Optimize control of endocrine conditions (thyroid, diabetes, Cushing syndrome) and chronic systemic diseases.​
  • Review medications that may affect prolactin or gonadotropin levels and adjust when feasible under medical supervision.​
• Routine healthcare:
  • Encourage regular menstrual tracking so changes are noticed promptly.​
  • Promote adolescent health education about normal puberty, menstrual patterns, and when to seek professional advice.​

Prognosis and outlook

The outlook for amenorrhea depends heavily on its cause, how long it has been present, and how quickly it is treated. Many forms of functional hypothalamic amenorrhea and medication‑related amenorrhea are reversible once the underlying trigger is removed, with resumption of ovulation and menses.​

Conditions such as primary ovarian insufficiency or congenital uterine absence typically result in permanent loss of natural fertility, though assisted reproductive techniques and gestational options may be available. With appropriate hormonal replacement and monitoring, long‑term health risks such as bone loss and cardiovascular disease can still be mitigated in these patients.​

Nursing care plan for patients with amenorrhea

Nursing assessment

• Collect a thorough menstrual history:
  • Age at menarche, cycle length, regularity, duration, flow, and date of last normal period.​
  • Document whether amenorrhea is primary or secondary and for how long it has persisted.​
• Screen for pregnancy and reproductive goals:
  • Check recent sexual activity, contraception, and pregnancy concerns; ensure a pregnancy test is arranged.​
  • Explore whether the patient desires pregnancy now or in the future to inform priorities of care.​
• Assess lifestyle and psychosocial factors:
  • Review diet, BMI, exercise intensity, training load, and any weight changes.​
  • Ask about stress, mood, sleep, and potential disordered eating or body image issues.​
• Identify associated symptoms and red flags:
  • Note galactorrhea, headaches, visual changes, hirsutism, acne, hot flushes, vaginal dryness, pelvic pain.​
  • Ask about chronic disease symptoms (e.g., abdominal pain, bowel changes, polyuria, fatigue).​
• Physical examination support:
  • Monitor vital signs, weight, and height trends; assist with pelvic examination when indicated.​
  • Observe for signs of malnutrition, hyperandrogenism, thyroid disease, or chronic illness.​

Nursing interventions

• Provide education and emotional support:
  • Offer clear explanations of amenorrhea, possible causes, investigations, and implications in understandable language.​
  • Validate emotional responses, address misconceptions, and involve partners or family if the patient consents.​
• Promote healthy lifestyle changes:
  • Encourage gradual, realistic nutrition plans to restore or maintain a healthy BMI, ideally in collaboration with dietitians.​
  • Support balanced exercise routines, negotiating with athletes or highly active patients to modify training safely.​
• Coordinate investigations and referrals:
  • Ensure timely pregnancy testing, laboratory samples, imaging, and follow‑up appointments are completed and results communicated.​
  • Advocate for specialist referral (gynecology, endocrinology, reproductive medicine, mental health) when indicated.​
• Support medication and treatment adherence:
  • Educate on correct use, benefits, and potential side effects of hormone therapy, dopamine agonists, thyroid or metabolic medications.​
  • Reinforce the importance of bone‑protective measures such as calcium, vitamin D, weight‑bearing exercise, and fall prevention.​
• Address fertility and contraceptive needs:
  • Facilitate discussions about fertility options, timing of pregnancy, and appropriate contraception during treatment.​
  • Provide preconception education where pregnancy is planned once cycles resume or with assisted reproduction.​
• Psychosocial and safeguarding interventions:
  • Screen sensitively for eating disorders, intimate partner violence, and mental health issues; follow local safeguarding pathways.​
  • Offer or arrange counseling, support groups, or psychological therapies when needed.​

Nursing evaluation

• Monitor menstrual outcomes:
  • Document return of menses, cycle regularity, and symptom changes over time.​
  • Evaluate whether treatment goals (e.g., cycle regulation, symptom relief, pregnancy) are being met.​
• Reassess physical and psychosocial status:
  • Track weight, BMI, bone health indicators if available, and presence of hypoestrogenic or hyperandrogenic symptoms.​
  • Review mood, coping strategies, adherence to lifestyle changes, and engagement with mental health or dietetic services.​
• Review treatment adherence and tolerability:
  • Confirm correct use of medications, manage side effects, and assess the need for dose or regimen adjustments.​
  • Ensure that follow‑up imaging, laboratory monitoring, and specialist reviews are attended.​
• Determine need for escalation:
  • Identify any new red‑flag symptoms (e.g., severe headaches, visual loss, acute pelvic pain) and communicate promptly to the medical team.​
  • Evaluate whether the patient’s goals or circumstances have changed, requiring revision of the care plan.​

Clinical signs of deterioration and when to escalate

Recognising early signs of deterioration in a patient with amenorrhea is essential, as serious endocrine, structural, or systemic conditions may underlie the symptom.​

Red‑flag signs and symptoms that should prompt urgent medical review or emergency referral include:

• Neurological and visual:
  • Sudden or severe headache, especially with nausea, vomiting, or altered consciousness, suggesting pituitary apoplexy or intracranial pathology.​
  • New visual field defects, double vision, or reduced visual acuity in a patient with suspected or known pituitary lesions.​
• Gynecological and abdominal:
  • Acute, severe pelvic or abdominal pain with amenorrhea, which may indicate ectopic pregnancy, ovarian torsion, or ruptured cyst.​
  • Heavy vaginal bleeding after a period of amenorrhea, particularly with hemodynamic instability.​
• Systemic and metabolic:
  • Marked unintentional weight loss, bradycardia, hypotension, hypothermia, or electrolyte abnormalities associated with suspected eating disorder.​
  • Features of adrenal crisis or severe endocrine dysfunction such as profound fatigue, abdominal pain, hypotension, or confusion.​
• Skeletal and general health:
  • Fragility fractures or severe bone pain in young individuals with long‑standing hypoestrogenic amenorrhea.​

Escalation pathways typically include immediate review by the on‑call medical or gynecology team, rapid imaging (e.g., CT/MRI) where indicated, and early involvement of endocrinology or neurosurgery for suspected pituitary emergencies. Nurses play a crucial role in detecting subtle changes, documenting them clearly, and advocating for timely escalation, especially in busy acute care settings.​

In clinical practice…

Amenorrhea often appears first as a “quiet” symptom noted during routine assessment, but it can open the door to important conversations. Patients may minimise or feel embarrassed about menstrual issues, so a calm, matter‑of‑fact approach and normalising language encourage more open disclosure.​

Practical tips that often help in day‑to‑day care include:

• Making menstrual history a standard part of admission and clinic assessments, not only in gynecology but also in medical, mental health, and sports‑related settings.​
• Using simple cycle‑tracking tools (apps, paper calendars) to help patients notice patterns and improvement once treatment starts.​
• Framing lifestyle advice around performance and long‑term health, especially for athletes and high achievers, rather than weight alone, to reduce resistance and guilt.​
• Collaborating closely with dietitians and mental health teams when disordered eating or body image concerns are suspected, and being persistent in gentle follow‑up.​
• Checking that written information is inclusive, non‑judgmental, and acknowledges that not everyone who menstruates identifies as female, while still being clinically precise.​

When patients see that the healthcare team takes amenorrhea seriously yet discusses it without stigma, they are often more willing to engage with investigations and longer‑term follow‑up.​

Disclaimer: This content is provided for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional, taking into account the individual patient’s medical history, current condition, and applicable clinical guidelines. Always seek the advice of a physician or other qualified healthcare provider with any questions regarding a medical condition.